Karolinska Universitetssjukhuset
Stockholm, Sweden
15 recruiting
Showing 1–15 of 15 trials
Recruiting
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
Relapsed Refractory Multiple Myeloma (RRMM)
Janssen-Cilag Ltd.900 enrolled68 locationsNCT06285318
Recruiting
Phase 2
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc.260 enrolled89 locationsNCT05968326
Recruiting
Phase 3
Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)
Metastatic Castration-resistant Prostate Cancer
Amgen675 enrolled164 locationsNCT06691984
Recruiting
Phase 3
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
Advanced Melanoma
Immunocore Ltd680 enrolled211 locationsNCT06112314
Recruiting
Phase 3
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
Colorectal Neoplasms
Janssen Research & Development, LLC700 enrolled229 locationsNCT06750094
Recruiting
Phase 3
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Colorectal Neoplasms
Janssen Research & Development, LLC1,000 enrolled231 locationsNCT06662786
Recruiting
Phase 2
A Phase 2, Open Label Study of PEmigatinib and REtifanlimab in Advanced Dedifferentiated LIposarcoma (PERELI)
Dedifferentiated Liposarcoma
Lund University Hospital33 enrolled4 locationsNCT06389799
Recruiting
Phase 3
MYTHS - MYocarditis THerapy With Steroids
Myocarditis Acute
Niguarda Hospital288 enrolled49 locationsNCT05150704
Recruiting
Phase 4
Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing
AsthmaInflammation
St. Olavs Hospital280 enrolled8 locationsNCT03889743
Recruiting
Phase 3
Stroke Prophylaxis With Apixaban in Chronic Kidney Disease Stage 5 Patients With Atrial Fibrillation
DeathAtrial FibrillationChronic Kidney Diseases+6 more
Region Stockholm1,400 enrolled34 locationsNCT05679024
Recruiting
Phase 2
Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy
Radiotherapy Side EffectCognitive ImpairmentBrain Tumor+4 more
Region Stockholm84 enrolled2 locationsNCT06051240
Recruiting
Biological Mechanisms Behind Resynchronization Therapy in Heart Failure
Heart FailureCardiac Remodeling, Ventricular
Region Stockholm220 enrolled1 locationNCT06140914
Recruiting
The European NAFLD Registry
Hepatocellular CarcinomaObesityCardiovascular Diseases+9 more
Newcastle University10,000 enrolled37 locationsNCT04442334
Recruiting
Phase 3
Induction Chemotherapy for Locally Recurrent Rectal Cancer
Recurrent Rectal Cancer
Catharina Ziekenhuis Eindhoven364 enrolled14 locationsNCT04389086
Recruiting
NORDTREAT Prospective Study on Inflammatory Bowel Disease
Ulcerative Colitis (UC)Crohn Disease (CD)Inflammatory Bowel Diseases (IBD)
University of Southern Denmark800 enrolled17 locationsNCT05414578